Paul Kemp


Chief Executive and Chief Scientific Officer, Intercytex

Paul Kemp has been involved in commercial regenerative medicine for over 20 years, and has a successful track record many aspects of private and public biotech business. This includes founding biotech companies, raising funding in Europe, US and Asia, taking a regenerative medicine company public, operating GMP facilities and clinical trials as well as launching marketing and selling cell-based products. Paul has extensive international regulatory expertise, is the inventor on several patents related to regenerative medicine products, and publishes and presents widely in the field. He holds a BSc from the University of Wales and a PhD from the University of Leeds, is Chairman of the Industrial Group of Regener8 and is on the editorial board of Regenerative Medicine

Funding Partners: